Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2000 | 1 |
2001 | 3 |
2024 | 0 |
Search Results
4 results
Results by year
Filters applied: . Clear all
Page 1
Mechanisms of action of quinone-containing alkylating agents. I: NQO1-directed drug development.
Front Biosci. 2000 Jul 1;5:D639-48. doi: 10.2741/beall.
Front Biosci. 2000.
PMID: 10877993
Review.
Rapid polyubiquitination and proteasomal degradation of a mutant form of NAD(P)H:quinone oxidoreductase 1.
Siegel D, Anwar A, Winski SL, Kepa JK, Zolman KL, Ross D.
Siegel D, et al.
Mol Pharmacol. 2001 Feb;59(2):263-8. doi: 10.1124/mol.59.2.263.
Mol Pharmacol. 2001.
PMID: 11160862
Item in Clipboard
Characterization of a mechanism-based inhibitor of NAD(P)H:quinone oxidoreductase 1 by biochemical, X-ray crystallographic, and mass spectrometric approaches.
Winski SL, Faig M, Bianchet MA, Siegel D, Swann E, Fung K, Duncan MW, Moody CJ, Amzel LM, Ross D.
Winski SL, et al.
Biochemistry. 2001 Dec 18;40(50):15135-42. doi: 10.1021/bi011324i.
Biochemistry. 2001.
PMID: 11735396
Item in Clipboard
Relationship between NAD(P)H:quinone oxidoreductase 1 (NQO1) levels in a series of stably transfected cell lines and susceptibility to antitumor quinones.
Winski SL, Swann E, Hargreaves RH, Dehn DL, Butler J, Moody CJ, Ross D.
Winski SL, et al.
Biochem Pharmacol. 2001 Jun 15;61(12):1509-16. doi: 10.1016/s0006-2952(01)00631-1.
Biochem Pharmacol. 2001.
PMID: 11377380
Item in Clipboard
Cite
Cite